rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Kimberly Jo Tzoumakas

Director

Company insider

Files Form 4 as: Director, The Oncology Institute; Director, Coherus Oncology; Director, SeaSpine Holdings.

In numbers

Trades disclosed
13
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
3
First trade
19 Feb 2019
Last trade
27 Jul 2026
Last filed
29 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
The Oncology InstituteDirector · Providers & Facilities · last 27 Jul 20260 buys · 0 sells
CHRS Coherus OncologyDirector · Biotechnology · last 3 Jun 20240 buys · 0 sells
SeaSpine HoldingsDirector · last 3 Jun 20200 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
27 Jul 2026filed 29 Jul 2026The Oncology InstituteProviders & FacilitiesSEC FORM 4 Code A—29,116 at $0.00filing
27 Jul 2026filed 29 Jul 2026The Oncology InstituteProviders & FacilitiesSEC FORM 4 Code A—29,116 at $0.00filing
7 Jul 2026filed 9 Jul 2026The Oncology InstituteProviders & FacilitiesSEC FORM 4 Code A—17,185 at $0.00filing
7 Jul 2026filed 9 Jul 2026The Oncology InstituteProviders & FacilitiesSEC FORM 4 Code A—17,185 at $0.00filing
3 Jun 2024filed 5 Jun 2024CHRS Coherus Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—112,000 at $0.00filing
7 Jun 2023filed 9 Jun 2023CHRS Coherus Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—38,250 at $0.00filing
7 Jan 2022filed 11 Feb 2022CHRS Coherus Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—27,000 at $0.00filing
7 Jan 2022filed 10 Jan 2022CHRS Coherus Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—27,000 at $0.00filing
11 Jan 2021filed 13 Jan 2021CHRS Coherus Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
30 Jul 2020filed 3 Aug 2020CHRS Coherus Oncologyoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
3 Jun 2020filed 5 Jun 2020SeaSpine HoldingsSEC FORM 4 Code A—8,488 at $0.00filing
29 May 2019filed 31 May 2019SeaSpine HoldingsSEC FORM 4 Code A—7,262 at $0.00filing
19 Feb 2019filed 20 Feb 2019SeaSpine HoldingsSEC FORM 4 Code A—5,920 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Brad HivelyDirector · Director at Starling Oncology, filing Form 4 there in the last year
Jorey Chernett10% owner · 10% owner at Starling Oncology, filing Form 4 there in the last year
Mohit KaushalDirector · Director at Oncology Institute, filing Form 4 there in the last year
Anne McGeorgeDirector · Director at Oncology Institute, filing Form 4 there in the last year
Mark StolperDirector · Director at Oncology Institute, filing Form 4 there in the last year